Users describe moderate energy and mood improvements plus small body-composition changes after several weeks at roughly 0.5 mg each peptide twice daily. Flushing and hunger occur, with stronger reactions tied to tesamorelin than the cjc/ipa blend. Baseline IGF-1 testing is emphasized to avoid worsening insulin resistance, and some participants prefer straight HGH over secretagogues. Cycles are often limited to 1-2 months followed by time off.
What this discussion establishesWhether secretagogues lose effectiveness with age or simply carry higher insulin-resistance risk than exogenous GH when IGF-1 is already optimal.
Still openHow much the observed body-composition changes would continue past eight weeks or compare directly to pharmaceutical GH in the same individuals.
Nothing here is advice.
Would anyone like to share what they've noticed from cjc and ipa? I'm getting ready to begin and would like details on dosing, timing, sleep changes, muscle gains, and similar points.
I'm also about to begin and would appreciate hearing what others have gone through.
Four weeks into a run of CJC-1295 without DAC plus ipamorelin. The product tested higher on the CJC side than expected, so my current shots are 0.546 mg CJC and 0.406 mg IPA morning and night, with the morning dose taken fasted. I also add 2 mg tesamorelin at night. Energy and outlook have both improved noticeably. No weight training is happening yet some muscle has appeared anyway. Happy to answer more questions.
Mind if I ask your age? I'm curious whether the combination produces smaller GH pulses as people get older, and at what point these peptides stop being worthwhile compared with actual growth hormone.
Checking IGF-1 before, during, and after seems the clearest way to judge results. Common patterns are five days on two off or one month on one month off. Age-based reference ranges exist, yet some longevity-focused users still like the stack. CJC and tesamorelin overlap in what they do. One thing I'd like to know is whether hunger increases and whether tirzepatide or retatrutide is also being used, since the GLP-1 response can apparently weaken when these peptides are added.
Do you notice much flushing right after the shot? Any histamine-type reactions?
My retatrutide progress seemed to stall for a month, and I'm wondering if it was the new batch or the addition of ipamorelin.
I'll cover the questions together. I'm 45 and accept that straight GH might work better at this age but the risk level feels too high so I'm staying with the peptides. Hunger is up more than the secretagogues alone would explain, yet it's tolerable. I've used tirzepatide long-term and am now raising retatrutide, recently taking 3.5 mg of the former and 6 mg of the latter. Flushing is moderate from the CJC/IPA shots and stronger with tesamorelin; both feel itchy and unpleasant but not enough to quit early. Scale weight stays roughly the same while waist measurements and clothing fit show improvement. The plan is to stop the CJC/IPA once the tesamorelin is finished, around day 55, then take at least a month off.
It's notable that the blend causes only moderate flushing while tesamorelin causes more. Have you considered Zyrtec to ease the histamine side? A nearby university runs DEXA scans for fifty dollars; maybe one near you offers something comparable.
Baseline IGF-1 testing matters a lot before starting ipamorelin. Age-adjusted optimal ranges run roughly 200-350 ng/mL for people in their twenties, 175-300 for thirties to fifties, 150-250 for early sixties, and 125-200 after that. Pushing the pathway when levels are already high can raise insulin resistance. Tesamorelin tends to worsen that risk even more. Knowing the reason for use matters more than simply copying a protocol.
Hunger control stayed good on retatrutide until the new batch and the start of ipamorelin. Weight jumped nine pounds and hasn't moved despite raising the dose from six to eight milligrams last week.
It hasn't done much for me beyond slightly better sleep since I began in November. At 47 I now think I would have gone straight to HGH. Hunger isn't strong the way it is with MK-677, and flushing happens but I don't mind it.
Could you share where the supporting data can be found? Not arguing, just genuinely interested.
The flushing itself never bothered me enough to stop. I did end the tesamorelin suddenly after three nights of worsening migraines that almost sent me to the ER; I realized I was still getting injection-site reactions from shots given five or more days earlier. Once I dropped the tesamorelin the migraines stopped within a week.
It's reasonable to wonder about this, and I feel sure I can steer you toward solid information without any hassle. The encouraging part is that none of it counts as hidden or up for debate, since it counts as standard knowledge in hormone science. Should you wish to explore more, useful keywords include connections between growth hormone and resistance to insulin, the way it counters insulin effects, age-based normal ranges for IGF-1, ties between acromegaly and problems tolerating glucose that can lead to diabetes, trials with tesamorelin that track fasting glucose plus HbA1c, and how GH secretagogues influence glucose handling. Facts on these mechanisms, typical lab values, and results from human studies have existed for many years and show up readily in summary articles along with official recommendations.
Thanks. I started without much prior reading. I'll spend time going through the material and decide on any changes.
If you have tried it, this topic is still open. Sign in to reply — it takes a minute.